3281 - 3290 of 7939 Results
Title
Year
-
OPENTitle: Cognitive Behavioral Therapy for Anxiety in Parkinsonʼs Disease: A Randomized Controlled TrialJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 11Start Page: 2539End Page: 2548Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28533Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28533Citation Count: 37
-
RESTRICTEDTitle: Role of Peripheral Immune Cells for Development and Recovery of Chronic PainJournal Name: Frontiers in ImmunologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fimmu.2021.641588Best OA location URL: https://www.frontiersin.org/articles/10.3389/fimmu.2021.641588/pdfCitation Count: 29
-
OPENTitle: Vascular Lesions, APOE ε4, and Tau Pathology in Alzheimer DiseaseJournal Name: Journal of Neuropathology & Experimental NeurologyPublisher: Oxford University Press (OUP)Vol: 80Issue #: 3Start Page: 240End Page: 246Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/jnen/nlaa160Best OA location URL: https://academic.oup.com/jnen/article-pdf/80/3/240/36335359/nlaa160.pdfCitation Count: 18
-
OPENTitle: β‐Blocker–Induced TremorJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 3Start Page: 449End Page: 452Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13176Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13176Citation Count: 4
-
OPENTitle: Association of autonomic symptoms with cerebrospinal fluid biomarkers in Parkinson disease and scans without evidence of dopaminergic deficitJournal Name: MedicinePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 100Issue #: 7Start Page: e24837End Page: e24837Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1097/md.0000000000024837Best OA location URL: https://doi.org/10.1097/md.0000000000024837Citation Count: 11
-
OPENTitle: LRRK2 Ablation Attenuates Alpha-Synuclein–Induced Neuroinflammation Without Affecting Neurodegeneration or Neuropathology In VivoJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 18Issue #: 2Start Page: 949End Page: 961Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s13311-021-01007-8Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-021-01007-8.pdfCitation Count: 12
-
RESTRICTEDTitle: Relationship of Neurofilament Light (NfL) and Cognitive Performance in a Sample of Mexican Americans with Normal Cognition, Mild Cognitive Impairment and DementiaJournal Name: Current Alzheimer ResearchPublisher: Bentham Science Publishers Ltd.Vol: 17Issue #: 13Start Page: 1214End Page: 1220Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2174/1567205018666210219105949Citation Count: 13
-
OPENTitle: Detection of α-synuclein in CSF by RT-QuIC in patients with isolated rapid-eye-movement sleep behaviour disorder: a longitudinal observational studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 20Issue #: 3Start Page: 203End Page: 212Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30449-xBest OA location URL: http://hdl.handle.net/20.500.11820/2546dc5d-292d-400c-a98d-20dd5d9c5621Citation Count: 220
-
OPENTitle: Identification of LRRK2 missense variants in the accelerating medicines partnership Parkinson’s disease cohortJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 30Issue #: 6Start Page: 454End Page: 466Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/hmg/ddab058Best OA location URL: https://academic.oup.com/hmg/article-pdf/30/6/454/37875911/ddab058.pdfCitation Count: 27
-
OPENTitle: Pharmacological validation of TDO as a target for Parkinson’s diseaseJournal Name: The FEBS JournalPublisher: WileyVol: 288Issue #: 14Start Page: 4311End Page: 4331Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/febs.15721Best OA location URL: https://dspace.library.uu.nl/bitstream/handle/1874/417446/The_FEBS_Journal_2021_Perez_Pardo_Pharmacological_validation_of_TDO_as_a_target_for_Parkinson_s_disease.pdf?sequence=1&isAllowed=yCitation Count: 17